Vicapsys Life Sciences, Inc. – OTC:VICP

Vicapsys Life Sciences stock price today

$1.77
-5.23
-74.71%
Financial Health
0
1
2
3
4
5
6
7
8
9

Vicapsys Life Sciences stock price monthly change

+40.00%
month

Vicapsys Life Sciences stock price quarterly change

+40.00%
quarter

Vicapsys Life Sciences stock price yearly change

+155.47%
year

Vicapsys Life Sciences key metrics

Market Cap
224.49M
Enterprise value
N/A
P/E
-50
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
-59.94
PEG ratio
-0.55
EPS
-0.04
Revenue
N/A
EBITDA
-721.90K
Income
-1.42M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Vicapsys Life Sciences stock price history

Vicapsys Life Sciences stock forecast

Vicapsys Life Sciences financial statements

Vicapsys Life Sciences, Inc. (OTC:VICP): Profit margin
Dec 2022 0 -832.83K
Mar 2023 0 -211.27K
Jun 2023 0 -135.69K
Sep 2023 0 -240.34K
Vicapsys Life Sciences, Inc. (OTC:VICP): Debt to assets
Dec 2022 72021 1.02M 1420.16%
Mar 2023 63293 1.20M 1903.31%
Jun 2023 378147 1.47M 389.18%
Sep 2023 208486 1.54M 739.79%
Vicapsys Life Sciences, Inc. (OTC:VICP): Cash Flow
Dec 2022 2.88K 0 -15.00K
Mar 2023 -9.95K 0 0
Jun 2023 -218.10K 0 445.24K
Sep 2023 -107.41K 0 -70.33K

Vicapsys Life Sciences alternative data

Vicapsys Life Sciences, Inc. (OTC:VICP): Employee count
Aug 2023 2
Sep 2023 2
Oct 2023 2
Nov 2023 2
Dec 2023 2
Jan 2024 2
Feb 2024 2
Mar 2024 2
Apr 2024 2
May 2024 2
Jun 2024 2
Jul 2024 2

Vicapsys Life Sciences other data

Vicapsys Life Sciences, Inc. (OTC:VICP): Insider trades (number of shares)
Period Buy Sel
Jan 2010 0 5000
Aug 2010 0 20000
Sep 2010 0 5000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
YURKOWSKI MICHAEL director
SSGI 5,000 N/A N/A
Sale
YURKOWSKI MICHAEL director
Common Stock 20,000 N/A N/A
Sale
YURKOWSKI MICHAEL director
Common Stock 5,000 N/A N/A
  • What's the price of Vicapsys Life Sciences stock today?

    One share of Vicapsys Life Sciences stock can currently be purchased for approximately $1.77.

  • When is Vicapsys Life Sciences's next earnings date?

    Unfortunately, Vicapsys Life Sciences's (VICP) next earnings date is currently unknown.

  • Does Vicapsys Life Sciences pay dividends?

    No, Vicapsys Life Sciences does not pay dividends.

  • How much money does Vicapsys Life Sciences make?

    Vicapsys Life Sciences has a market capitalization of 224.49M.

  • What is Vicapsys Life Sciences's stock symbol?

    Vicapsys Life Sciences, Inc. is traded on the OTC under the ticker symbol "VICP".

  • What is Vicapsys Life Sciences's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Vicapsys Life Sciences?

    Shares of Vicapsys Life Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Vicapsys Life Sciences have?

    As Jul 2024, Vicapsys Life Sciences employs 2 workers.

  • When Vicapsys Life Sciences went public?

    Vicapsys Life Sciences, Inc. is publicly traded company for more then 27 years since IPO on 23 Feb 1998.

  • What is Vicapsys Life Sciences's official website?

    The official website for Vicapsys Life Sciences is vicapsys.com.

  • Where are Vicapsys Life Sciences's headquarters?

    Vicapsys Life Sciences is headquartered at 1735 Buford Highway, Cumming, GA.

  • How can i contact Vicapsys Life Sciences?

    Vicapsys Life Sciences's mailing address is 1735 Buford Highway, Cumming, GA and company can be reached via phone at +972 8918033.

Vicapsys Life Sciences company profile:

Vicapsys Life Sciences, Inc.

vicapsys.com
Exchange:

OTC

Full time employees:

2

Industry:

Biotechnology

Sector:

Healthcare

Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN proprietary product. Its product is applied to transplantation therapies and related stem-cell applications in the transplantation field. The company is also developing VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia.

1735 Buford Highway
Cumming, GA 30024

CIK: 0001468639
ISIN: US92560A1060
CUSIP: 92560A106